SLC6A4 and persistent fetal circulation syndrome: Importantly, maternal use of pharmacologic SERT inhibitors (SSRIs) in the third trimester of pregnancy has been linked to the development of PPHN, and altered pulmonary vasculature has been proposed as a possible mechanism [22, 23].